Studies with prazosin--a new effective hypotensive agent. II. Two double-blind cross-over studies comparing the effects of prazosin and hydrallazine
- PMID: 331040
Studies with prazosin--a new effective hypotensive agent. II. Two double-blind cross-over studies comparing the effects of prazosin and hydrallazine
Similar articles
-
Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension.Drugs. 1977 Sep;14(3):163-97. doi: 10.2165/00003495-197714030-00002. Drugs. 1977. PMID: 143363 Review. No abstract available.
-
Studies with prazosin--a new effective hypotensive agent. III. An acute double-blind cross-over study comparing the effects of single doses of prazosin and hydrallazine in combination with propranolol and a diuretic.Med J Aust. 1978 Jan 14;1(1):45-8. Med J Aust. 1978. PMID: 368538 Clinical Trial.
-
[Cross-over trial with Peripress (prazosin) and Apresolin (hydralazin), both in combination with beta-blocker].Tidsskr Nor Laegeforen. 1980 Jan 30;100(3):148-49. Tidsskr Nor Laegeforen. 1980. PMID: 6992338 Clinical Trial. Norwegian. No abstract available.
-
A cross-over study between hydrallazine and prazosin.Clin Sci Mol Med Suppl. 1976 Dec;3:621s-623s. doi: 10.1042/cs051621s. Clin Sci Mol Med Suppl. 1976. PMID: 799569 Clinical Trial.
-
Prazosin: a review of clinical experience in hypertension.Ther Umsch. 1981;38 Suppl:28-32. Ther Umsch. 1981. PMID: 6122285 Review. No abstract available.
Cited by
-
Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension.Drugs. 1977 Sep;14(3):163-97. doi: 10.2165/00003495-197714030-00002. Drugs. 1977. PMID: 143363 Review. No abstract available.
-
The addition of prazosin to standard triple therapy in the treatment of severe hypertension.Br J Clin Pharmacol. 1982 Apr;13(4):539-41. doi: 10.1111/j.1365-2125.1982.tb01418.x. Br J Clin Pharmacol. 1982. PMID: 7066169 Free PMC article.